@stevenwryder1
ID: 1511360604098998275
calendar_today05-04-2022 15:10:42
2 Tweet
12 Followers
150 Following
3 years ago
I
9 months ago
🚨 Today, Rallybio announced the initiation of the Phase 2 clinical trial investigating RLYB212 in pregnant women at higher risk for HPA-1a alloimmunization and fetal and neonatal alloimmune thrombocytopenia (FNAIT).